Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
Clinical trial NCT01893996 · COMPLETED
Trial details
- NCT number
- NCT01893996
- Sponsor
- Jonathan Graf
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2017-07-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.